The anti-Ebola vaccine is about to be tested on a large scale

According to WHO experts, tens of thousands of people in West Africa will be able to test the Ebola vaccine early next year.

On October 21, the World Health Organization (WHO) announced that tens of thousands of people in West Africa could be vaccinated against Ebola vaccines starting in January 2015 because of positive results. obtained from this vaccine.

Accordingly, two types of vaccines - one of GlaxoSmithKline and one of the Canadian Public Health Agency are being considered as the two most potential candidates to help fight Ebola virus infection on a large scale.

WHO said it has put the two vaccines to test with 500 volunteers from countries such as the US, Europe and Africa.

Test results for users' security will be announced in December before being officially put into widespread use early next year.

Marie-Paule Kieny, deputy director of the health system of the World Health Organization (WHO), said: "This trial will be conducted with a large number of volunteers.

This will be an important test when determining the safety and the ability to create immunity in humans for this type of vaccine. With that, we can determine the direction to deploy this vaccine in the same dosage ".

This is considered an important step when at this time, no one can know exactly what a small or large dose of vaccine will help protect them against the Ebola virus. The researchers said the largest dose used in the trial would be 1,000 times the smallest dose.

Besides these two vaccines, there are also some US Ebola virus vaccines that have been developed and promise to help users. Not only that, the French government is also working on testing a Japanese-produced Ebola medicine.

Epidemiologist Stephen Morse of Columbia University School of Public Health said: "If the test is successful, we can come up with a strategy similar to the vaccination strategy used in eradication. Smallpox".

Researchers all agree that, although it is still possible that we will fail, everyone is trying, hoping to bring these vaccines to trial in West Africa early next year.